Diabetes Insights - Breakthroughs and Innovators Titelbild

Diabetes Insights - Breakthroughs and Innovators

Diabetes Insights - Breakthroughs and Innovators

Von: EASD - European Association for the Study of Diabetes
Jetzt kostenlos hören, ohne Abo

Nur 0,99 € pro Monat für die ersten 3 Monate

Danach 9.95 € pro Monat. Bedingungen gelten.

Über diesen Titel

 EASD presents: Diabetes Insights - Breakthroughs and Innovators Join us for expert interviews and discussions on the latest advances in diabetes research. Discover how groundbreaking medicines and cutting-edge technologies are shaping the future of diabetes treatment and management. Get inspired by the stories of distinguished researchers whose discoveries and contributions have transformed our understanding of diabetes. These podcasts were recorded at the EASD Annual Meeting 2024 in Madrid, Spain. You can learn more about the research discussed by watching the scientific presentations in the EASD Media Centre (https://www.easd.org/media-centre/home.html). New episode released every Friday. Wissenschaft
Folgen
  • What are the Hot Topics in Diabetes Research from a Journal's Perspective - Diabetologia

    What are the Hot Topics in Diabetes Research from a Journal's Perspective - Diabetologia
    Jan 9 2026
    In our first episode of 2026, Prof. Hindrik Mulder, Editor-in-Chief of Diabetologia, offers a journal’s-eye view of the most exciting and challenging developments in diabetes research today. Drawing on his unique overview of submissions from across the global research community, prof. Mulder discusses emerging breakthroughs such as hypoimmune stem cell-based therapies that are transforming from theoretical possibilities into scalable, off-the-shelf treatments for diabetes. Prof. Mulder discusses how these innovations could revolutionise diabetes care by overcoming the historical barriers of islet transplantation. We further explore Diabetologia's special 2025 issue on "Opportunities and Challenges in Diabetes," which tackles the critical issues of healthcare disparity, access, and equity. Prof. Mulder passionately addresses why diversity in research is essential to understanding disease heterogeneity and why the scientific community must continue advocating for inclusive research despite political headwinds. Learn about the journal's innovative approach to incorporating patient perspectives in research design, the appointment of a dedicated DEI editor, and the exciting launch of Metabologia - Diabetologia's new sister journal - covering the expanding landscape of metabolic disorders. This conversation reminds us that embracing complexity and acknowledging what we don't know is fundamental to advancing diabetes science.
    Mehr anzeigen Weniger anzeigen
    15 Min.
  • SURPASSing Therapeutic Challenges of Paediatric Type 2 Diabetes with Tirzepatide

    SURPASSing Therapeutic Challenges of Paediatric Type 2 Diabetes with Tirzepatide
    Dec 19 2025
    In this episode, Dr. Tamara Hannon (Indiana University Health) and Prof. Martin Wabitsch (Universtätsklinikum Ulm) unpack the findings of the SURPASS-PEDS trial - the first study to evaluate the dual GIP/GLP-1 receptor agonist tirzepatide in adolescents with type 2 diabetes. With youth-onset type 2 diabetes rising sharply across the US and Europe, and with young people experiencing faster beta-cell decline, more severe obesity, and greater socioeconomic burdens, the need for effective therapies has never been greater. They discuss why adolescent disease differs fundamentally from adult type 2 diabetes, why weight-loss expectations cannot be compared across age groups, and how tirzepatide not only reduces HbA1c but also halts the extreme weight-gain velocity commonly seen in this population. They also reflect on what early intervention could mean for long-term metabolic health, how guidelines may evolve, and how better treatment options could transform quality of life for young people living with type 2 diabetes. This conversation highlights why youth-onset type 2 diabetes is fundamentally different from adult disease, why weight loss behaves differently in children, and how early intervention could change the life course for young people at high risk of long-term complications.
    Mehr anzeigen Weniger anzeigen
    13 Min.
  • The EASD's First Clinical Guideline: Assessment and Management of Diabetes Distress

    The EASD's First Clinical Guideline: Assessment and Management of Diabetes Distress
    Dec 12 2025
    In this episode, EASD presents its inaugural clinical guideline on diabetes distress. Drawing on two years of multidisciplinary work, the guideline was developed by clinicians, methodologists, psychologists and people with lived experience. Prof. Jane Speight, Prof. Richard Holt and patient-advocate Michelle Law describe what diabetes distress is (the emotional burden tied to daily self-management) and why routine assessment and supportive care must become part of standard practice. The guideline sets out eight good practice statements to help clinicians normalise conversations about emotional wellbeing, plus graded recommendations for managing distress in adults with type 1 and type 2 diabetes. Psychological interventions are endorsed where evidence supports them, and clinic-level actions that clinicians can deliver without referral are highlighted. The panel also discusses evidence gaps, the need for practical tools and training, and how people living with diabetes can drive implementation by asking for these conversations in clinic. Join EASD TV to hear how this guideline aims to transform diabetes care by putting emotional wellbeing alongside clinical outcomes.
    Mehr anzeigen Weniger anzeigen
    16 Min.
Noch keine Rezensionen vorhanden